Danaher - a large U.S. corporation - owns many smaller biotech companies, including Cepheid. Cepheid designs and manufactures diagnostic tests. Their TB GeneXpert test determines whether someone has tuberculosis and if the infection is drug resistant or not, enabling effective treatment.
Using the "printer ink" business model, Danaher sells the testing machines at a reasonable price, but WAAAY overcharges for the test cartridges themselves, especially the cartridges that show whether the type of TB someone has is likely to be drug-resistant, meaning that even when people can get a diagnosis, they may end up wasting valuable time on treatments that are less likely to be effective because they couldn't access the more advanced diagnostic cartridge, which, by the way, costs the SAME AMOUNT OF MONEY TO MANUFACTURER AS THE BASIC DIAGNOSTIC CARTRIDGE. Danaher is PURPOSELY price-gouging and it's costing thousands of lives a year.
But there's something we can do about it.
Contact Danaher and let them know to put #PeopleOverProfits and start selling their diagnostic cartridges for $5. It's #TimeFor5.
Danaher's corporate office: 202-828-0850
Social Media: @DanaherCorp and @CepheidNews
For email, phone, and social media templates, (and more info and graphics to share) visit TBFIGHTERS.ORG